Astellas Accused Of Delaying Generic Drug Approval
Astellas Pharma US Inc. was hit with a putative class action by a union benefit fund Wednesday in Massachusetts federal court for allegedly keeping a generic version of its immune-suppressing drug...To view the full article, register now.
Already a subscriber? Click here to view full article